Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cheryl Meng is active.

Publication


Featured researches published by Cheryl Meng.


Environmental Health Perspectives | 2011

Rotenone, Paraquat, and Parkinson’s Disease

Caroline M. Tanner; Freya Kamel; G. Webster Ross; Jane A. Hoppin; Samuel M. Goldman; Monica Korell; Connie Marras; Grace S. Bhudhikanok; Meike Kasten; Anabel Chade; Kathleen Comyns; Marie Richards; Cheryl Meng; Benjamin Priestley; Hubert H. Fernandez; Franca Cambi; David M. Umbach; Aaron Blair; Dale P. Sandler; J. William Langston

Background Mitochondrial dysfunction and oxidative stress are pathophysiologic mechanisms implicated in experimental models and genetic forms of Parkinson’s disease (PD). Certain pesticides may affect these mechanisms, but no pesticide has been definitively associated with PD in humans. Objectives Our goal was to determine whether pesticides that cause mitochondrial dysfunction or oxidative stress are associated with PD or clinical features of parkinsonism in humans. Methods We assessed lifetime use of pesticides selected by mechanism in a case–control study nested in the Agricultural Health Study (AHS). PD was diagnosed by movement disorders specialists. Controls were a stratified random sample of all AHS participants frequency-matched to cases by age, sex, and state at approximately three controls: one case. Results In 110 PD cases and 358 controls, PD was associated with use of a group of pesticides that inhibit mitochondrial complex I [odds ratio (OR) = 1.7; 95% confidence interval (CI), 1.0–2.8] including rotenone (OR = 2.5; 95% CI, 1.3–4.7) and with use of a group of pesticides that cause oxidative stress (OR = 2.0; 95% CI, 1.2–3.6), including paraquat (OR = 2.5; 95% CI, 1.4–4.7). Conclusions PD was positively associated with two groups of pesticides defined by mechanisms implicated experimentally—those that impair mitochondrial function and those that increase oxidative stress—supporting a role for these mechanisms in PD pathophysiology.


JAMA Neurology | 2009

Occupation and Risk of Parkinsonism: A Multicenter Case-Control Study

Caroline M. Tanner; G. Webster Ross; Sarah A. Jewell; Robert A. Hauser; Joseph Jankovic; Stewart A. Factor; Susan Bressman; Amanda Deligtisch; Connie Marras; Kelly E. Lyons; Grace S. Bhudhikanok; Diana F. Roucoux; Cheryl Meng; Robert D. Abbott; J. William Langston

BACKGROUND We examined risk of parkinsonism in occupations (agriculture, education, health care, welding, and mining) and toxicant exposures (solvents and pesticides) putatively associated with parkinsonism. OBJECTIVE To investigate occupations, specific job tasks, or exposures and risk of parkinsonism and clinical subtypes. DESIGN Case-control. SETTING Eight movement disorders centers in North America. PARTICIPANTS Inclusion criteria were parkinsonism (>or=2 cardinal signs), diagnosis within 8 years of recruitment (to minimize survival bias), and ability to participate in detailed telephone interviews. Control subjects were primarily nonblood relatives or acquaintances of patients. MAIN OUTCOME MEASURES This multicenter case-control study compared lifelong occupational and job task histories to determine associations with parkinsonism and certain clinical subtypes (postural instability and gait difficulty and age at diagnosis <or=50 years). RESULTS Findings in 519 cases and 511 controls were analyzed. Work in agriculture, education, health care, or welding was not associated with increased risk of parkinsonism. Unexpected increased risks associated with legal, construction and extraction, or religious occupations were not maintained after adjustment for duration. Risk of parkinsonism increased with pesticide use (odds ratio, 1.90; 95% confidence interval, 1.12-3.21), use of any of 8 pesticides mechanistically associated with experimental parkinsonism (2.20; 1.02-4.75), and use of 2,4-dichlorophenoxyacetic acid (2.59; 1.03-6.48). None of the specific occupations, job tasks, or task-related exposures were associated with younger age at diagnosis (<or=50 years). Ever working in business and finance, legal occupations, construction and extraction, or transportation and material moving was associated with postural instability and gait difficulty subtype of parkinsonism. Tobacco use was inversely associated with parkinsonism risk. CONCLUSION The association of disease risk with pesticides support a toxicant-induced cause of parkinsonism.


Annals of Neurology | 2012

Solvent exposures and parkinson disease risk in twins

Samuel M. Goldman; Patricia J. Quinlan; G. Webster Ross; Connie Marras; Cheryl Meng; Grace S. Bhudhikanok; Kathleen Comyns; Monica Korell; Anabel Chade; Meike Kasten; Benjamin Priestley; Kelvin L. Chou; Hubert H. Fernandez; Franca Cambi; J. William Langston; Caroline M. Tanner

Several case reports have linked solvent exposure to Parkinson disease (PD), but few studies have assessed associations with specific agents using an analytic epidemiologic design. We tested the hypothesis that exposure to specific solvents is associated with PD risk using a discordant twin pair design.


Annals of Neurology | 2012

Head Injury, Alpha-Synuclein Rep1 and Parkinson’s Disease

Samuel M. Goldman; Freya Kamel; G. Webster Ross; Sarah A. Jewell; Grace S. Bhudhikanok; David M. Umbach; Connie Marras; Robert A. Hauser; Joseph Jankovic; Stewart A. Factor; Susan Bressman; Kelly E. Lyons; Cheryl Meng; Monica Korell; Diana F. Roucoux; Jane A. Hoppin; Dale P. Sandler; J. William Langston; Caroline M. Tanner

To test the hypothesis that variability in SNCA Rep1, a polymorphic dinucleotide microsatellite in the promoter region of the gene encoding α‐synuclein, modifies the association between head injury and Parkinsons disease (PD) risk.


Parkinsonism & Related Disorders | 2014

Dietary Fat Intake, Pesticide Use, and Parkinson’s Disease

Freya Kamel; Samuel M. Goldman; David M. Umbach; Honglei Chen; Gina Richardson; Marie Richards Barber; Cheryl Meng; Connie Marras; Monica Korell; Meike Kasten; Jane A. Hoppin; Kathleen Comyns; Anabel Chade; Aaron Blair; Grace S. Bhudhikanok; G. Webster Ross; J. William Langston; Dale P. Sandler; Caroline M. Tanner

BACKGROUND Dietary fat intake may modify Parkinsons disease (PD) risk directly or by altering the response to environmental neurotoxicants including pesticides. METHODS We conducted a case-control study of PD nested in the Agricultural Health Study (AHS), a cohort of pesticide applicators and spouses. We evaluated diet and pesticide use before diagnosis in 89 PD cases, confirmed by movement disorder specialists, or a corresponding date in 336 frequency-matched controls. Associations were evaluated using multivariate logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS In the AHS, PD was inversely associated with N-3 polyunsaturated fatty acids (PUFAs) (OR 0.4, 95% CI 0.2-0.8 for highest vs. lowest tertile) and the N-3 precursor α-linolenic acid (0.4, 0.2-0.8). In a meta-analysis of nine studies, including the present one, PD was inversely associated with α-linolenic acid (0.81, 0.68-0.96). In the AHS, associations of PD with the pesticides paraquat and rotenone were modified by fat intake. The OR for paraquat was 4.2 (1.5-12) in individuals with PUFA intake below the median but 1.2 (0.4-3.4) in those with higher intake (p-interaction = 0.10). The OR for rotenone was 5.8 (2.3-15) in those with saturated fat intake above the median but 1.5 (0.5-4.2) in those with lower intake (p-interaction = 0.02). CONCLUSIONS PUFA intake was consistently associated with lower PD risk, and dietary fats modified the association of PD risk with pesticide exposure. If confirmed, these findings suggest that a diet high in PUFAs and low in saturated fats might reduce risk of PD.


Movement Disorders | 2012

Genetic Modification of the Association of Paraquat and Parkinson’s Disease

Samuel M. Goldman; Freya Kamel; G. Webster Ross; Grace S. Bhudhikanok; Jane A. Hoppin; Monica Korell; Connie Marras; Cheryl Meng; David M. Umbach; Meike Kasten; Anabel Chade; Kathleen Comyns; Marie Richards; Dale P. Sandler; Aaron Blair; J. William Langston; Caroline M. Tanner

Paraquat is one of the most widely used herbicides worldwide. It produces a Parkinsons disease (PD) model in rodents through redox cycling and oxidative stress (OS) and is associated with PD risk in humans. Glutathione transferases provide cellular protection against OS and could potentially modulate paraquat toxicity. We investigated PD risk associated with paraquat use in individuals with homozygous deletions of the genes encoding glutathione S‐transferase M1 (GSTM1) or T1 (GSTT1). Eighty‐seven PD subjects and 343 matched controls were recruited from the Agricultural Health Study, a study of licensed pesticide applicators and spouses in Iowa and North Carolina. PD was confirmed by in‐person examination. Paraquat use and covariates were determined by interview. We genotyped subjects for homozygous deletions of GSTM1 (GSTM1*0) and GSTT1 (GSTT1*0) and tested interaction between paraquat use and genotype using logistic regression. Two hundred and twenty‐three (52%) subjects had GSTM1*0, 95 (22%) had GSTT1*0, and 73 (17%; all men) used paraquat. After adjustment for potential confounders, there was no interaction with GSTM1. In contrast, GSTT1 genotype significantly modified the association between paraquat and PD. In men with functional GSTT1, the odds ratio (OR) for association of PD with paraquat use was 1.5 (95% confidence interval [CI]: 0.6–3.6); in men with GSTT1*0, the OR was 11.1 (95% CI: 3.0–44.6; P interaction: 0.027). Although replication is needed, our results suggest that PD risk from paraquat exposure might be particularly high in individuals lacking GSTT1. GSTT1*0 is common and could potentially identify a large subpopulation at high risk of PD from oxidative stressors such as paraquat.


Environment International | 2015

Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease

Melissa Furlong; Caroline M. Tanner; Samuel M. Goldman; Grace S. Bhudhikanok; Aaron Blair; Anabel Chade; Kathleen Comyns; Jane A. Hoppin; Meike Kasten; Monica Korell; J. William Langston; Connie Marras; Cheryl Meng; Marie Richards; G. Webster Ross; David M. Umbach; Dale P. Sandler; Freya Kamel

Pesticides have been associated with Parkinsons disease (PD), and protective gloves and workplace hygiene can reduce pesticide exposure. We assessed whether use of gloves and workplace hygiene modified associations between pesticides and PD. The Farming and Movement Evaluation (FAME) study is a nested case-control study within the Agricultural Health Study. Use of protective gloves, other PPE, and hygiene practices were determined by questionnaire (69 cases and 237 controls were included). We considered interactions of gloves and hygiene with ever-use of pesticides for all pesticides with ≥5 exposed and unexposed cases and controls in each glove-use stratum (paraquat, permethrin, rotenone, and trifluralin). 61% of respondents consistently used protective gloves and 87% consistently used ≥2 hygiene practices. Protective glove use modified the associations of paraquat and permethrin with PD: neither pesticide was associated with PD among protective glove users, while both pesticides were associated with PD among non-users (paraquat OR 3.9 [95% CI 1.3, 11.7], interaction p=0.15; permethrin OR 4.3 [95% CI 1.2, 15.6] interaction p=0.05). Rotenone was associated with PD regardless of glove use. Trifluralin was associated with PD among participants who used <2 hygiene practices (OR 5.5 [95% CI 1.1, 27.1]) but was not associated with PD among participants who used 2 or more practices (interaction p=0.02). Although sample size was limited in the FAME study, protective glove use and hygiene practices appeared to be important modifiers of the association between pesticides and PD and may reduce risk of PD associated with certain pesticides.


Movement Disorders | 2014

A practical approach to remote longitudinal follow-up of Parkinson's disease: The FOUND study

Caroline M. Tanner; Cheryl Meng; Bernard Ravina; Anthony E. Lang; Roger Kurlan; Kenneth Marek; David Oakes; John Seibyl; Emily Flagg; Lisa Gauger; Dolores Guest; Christopher G. Goetz; Karl Kieburtz; Diane DiEuliis; Stanley Fahn; Robin Elliott; Ira Shoulson

The objective of this study was to examine a remote method for maintaining long‐term contact with Parkinsons disease (PD) patients participating in clinical studies. Long‐term follow‐up of PD patients is needed to fill critical information gaps on progression, biomarkers, and treatment. Prospective in‐person assessment can be costly and may be impossible for some patients. Remote assessment using mail and telephone contact may be a practical follow‐up method. Patients enrolled in the multi‐center Longitudinal and Biomarker Study in Parkinsons Disease (LABS‐PD) in‐person follow‐up study in 2006 were invited to enroll in Follow‐up of Persons With Neurologic Diseases (FOUND), which is overseen by a single center under a separate, central institutional review board protocol. FOUND uses mailed questionnaires and telephone interviews to assess PD status. FOUND follow‐up continued when LABS‐PD in‐person visits ended in 2011. Retention and agreement between remote and in‐person assessments were determined. In total, 422 of 499 (84.5%) of eligible patients volunteered, AND 96% of participants were retained. Of 60 patients who withdrew consent from LABS‐PD, 51 were retained in FOUND. Of 341 patients who were active in LABS‐PD, 340 were retained in FOUND (99.7%) when the in‐person visits ceased. Exact agreement between remote and in‐person assessments was ≥ 80% for diagnosis, disease features (eg, dyskinesias), and PD medication. Correlation between expert‐rated and self‐reported Unified Parkinsons Disease Rating Scale and Movement Disorder Society Unified Parkinsons Disease Rating Scale, which were examined at times separated by several months, was moderate or substantial for most items. Retention was excellent using remote follow‐up of research participants with PD, providing a safety net when combined with in‐person visits, and also is effective as a stand‐alone assessment method, providing a useful alternative when in‐person evaluation is not feasible.


Parkinsonism & Related Disorders | 2009

Health related quality of life in early Parkinson's disease: Impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort

Zhaohui Qin; Liyan Zhang; Fei Sun; Xianghua Fang; Cheryl Meng; Caroline M. Tanner; Piu Chan


Movement Disorders | 2014

Peptidoglycan Recognition Protein Genes and Risk of Parkinson’s Disease

Samuel M. Goldman; Freya Kamel; G. Webster Ross; Sarah A. Jewell; Connie Marras; Jane A. Hoppin; David M. Umbach; Grace S. Bhudhikanok; Cheryl Meng; Monica Korell; Kathleen Comyns; Robert A. Hauser; Joseph Jankovic; Stewart A. Factor; Susan Bressman; Kelly E. Lyons; Dale P. Sandler; J. William Langston; Caroline M. Tanner

Collaboration


Dive into the Cheryl Meng's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Connie Marras

Toronto Western Hospital

View shared research outputs
Top Co-Authors

Avatar

G. Webster Ross

University of Hawaii at Manoa

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Monica Korell

University of California

View shared research outputs
Top Co-Authors

Avatar

J. William Langston

Santa Clara Valley Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David M. Umbach

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Freya Kamel

Research Triangle Park

View shared research outputs
Researchain Logo
Decentralizing Knowledge